| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| INCY | INCYTE CORP | EVP & Chief Medical Officer | $10.5M | -$2.71M | -20.5% | Nov 5, 2025 |
| THRX | Theseus Pharmaceuticals, Inc. | Director | $0 | Feb 14, 2024 | ||
| KURA | Kura Oncology, Inc. | Director | Jun 21, 2022 | |||
| RPTX | Repare Therapeutics Inc. | Director | Jun 17, 2024 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|